BAYR.Y Stock Overview
Operates as a life science company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bayer Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.15 |
| 52 Week High | €9.79 |
| 52 Week Low | €5.05 |
| Beta | 1 |
| 11 Month Change | -26.32% |
| 3 Month Change | -33.27% |
| 1 Year Change | -42.20% |
| 33 Year Change | -60.17% |
| 5 Year Change | -72.72% |
| Change since IPO | 16.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| BAYR.Y | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -3.9% | 1.6% | 2.2% |
| 1Y | -42.2% | 9.9% | 31.6% |
Return vs Industry: BAYR.Y underperformed the US Pharmaceuticals industry which returned 10% over the past year.
Return vs Market: BAYR.Y underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| BAYR.Y volatility | |
|---|---|
| BAYR.Y Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BAYR.Y has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BAYR.Y's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1863 | 94,245 | Bill Anderson | www.bayer.com |
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.
Bayer Aktiengesellschaft Fundamentals Summary
| BAYR.Y fundamental statistics | |
|---|---|
| Market cap | US$20.26b |
| Earnings (TTM) | -US$916.38m |
| Revenue (TTM) | US$48.67b |
0.4x
P/S Ratio-22.1x
P/E RatioIs BAYR.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAYR.Y income statement (TTM) | |
|---|---|
| Revenue | €46.74b |
| Cost of Revenue | €20.03b |
| Gross Profit | €26.71b |
| Other Expenses | €27.59b |
| Earnings | -€880.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 05, 2025
| Earnings per share (EPS) | -0.90 |
| Gross Margin | 57.15% |
| Net Profit Margin | -1.88% |
| Debt/Equity Ratio | 134.1% |
How did BAYR.Y perform over the long term?
See historical performance and comparison